These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 18972075

  • 1. Systemic therapy of hepatocellular carcinoma: are we making progress?
    Roxburgh P, Evans TR.
    Adv Ther; 2008 Nov; 25(11):1089-104. PubMed ID: 18972075
    [Abstract] [Full Text] [Related]

  • 2. Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
    Choi JY.
    Oncology; 2011 Nov; 81 Suppl 1():141-7. PubMed ID: 22212948
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Positioning of a molecular-targeted agent, sorafenib, in the treatment algorithm for hepatocellular carcinoma and implication of many complete remission cases in Japan.
    Kudo M, Ueshima K.
    Oncology; 2010 Jul; 78 Suppl 1():154-66. PubMed ID: 20616599
    [Abstract] [Full Text] [Related]

  • 5. Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?
    Lencioni R, Chen XP, Dagher L, Venook AP.
    Oncologist; 2010 Jul; 15 Suppl 4():42-52. PubMed ID: 21115580
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sorafenib in advanced hepatocellular carcinoma.
    Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J, SHARP Investigators Study Group.
    N Engl J Med; 2008 Jul 24; 359(4):378-90. PubMed ID: 18650514
    [Abstract] [Full Text] [Related]

  • 11. Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents.
    Chaparro M, González Moreno L, Trapero-Marugán M, Medina J, Moreno-Otero R.
    Aliment Pharmacol Ther; 2008 Dec 01; 28(11-12):1269-77. PubMed ID: 18808443
    [Abstract] [Full Text] [Related]

  • 12. Emerging strategies in the treatment of advanced hepatocellular carcinoma: the role of targeted therapies.
    Lord R, Suddle A, Ross PJ.
    Int J Clin Pract; 2011 Feb 01; 65(2):182-8. PubMed ID: 21235699
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.
    Wörns MA, Weinmann A, Pfingst K, Schulte-Sasse C, Messow CM, Schulze-Bergkamen H, Teufel A, Schuchmann M, Kanzler S, Düber C, Otto G, Galle PR.
    J Clin Gastroenterol; 2009 Feb 01; 43(5):489-95. PubMed ID: 19247201
    [Abstract] [Full Text] [Related]

  • 14. Assessment of the treatment response of HCC.
    Kim KW, Lee JM, Choi BI.
    Abdom Imaging; 2011 Jun 01; 36(3):300-14. PubMed ID: 21279353
    [Abstract] [Full Text] [Related]

  • 15. Sorafenib for the treatment of unresectable hepatocellular carcinoma.
    Kane RC, Farrell AT, Madabushi R, Booth B, Chattopadhyay S, Sridhara R, Justice R, Pazdur R.
    Oncologist; 2009 Jan 01; 14(1):95-100. PubMed ID: 19144678
    [Abstract] [Full Text] [Related]

  • 16. Molecularly targeted therapies for hepatocellular carcinoma: sorafenib as a stepping stone.
    Kim HY, Park JW.
    Dig Dis; 2011 Jan 01; 29(3):303-9. PubMed ID: 21829021
    [Abstract] [Full Text] [Related]

  • 17. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma.
    Abou-Alfa GK, Schwartz L, Ricci S, Amadori D, Santoro A, Figer A, De Greve J, Douillard JY, Lathia C, Schwartz B, Taylor I, Moscovici M, Saltz LB.
    J Clin Oncol; 2006 Sep 10; 24(26):4293-300. PubMed ID: 16908937
    [Abstract] [Full Text] [Related]

  • 18. Systemic therapies in hepatocellular carcinoma.
    Wörns MA, Weinmann A, Schuchmann M, Galle PR.
    Dig Dis; 2009 Sep 10; 27(2):175-88. PubMed ID: 19546557
    [Abstract] [Full Text] [Related]

  • 19. Systemic chemotherapy of hepatocellular carcinoma--Korean experience.
    Lee HC.
    Oncology; 2008 Sep 10; 75 Suppl 1():114-8. PubMed ID: 19092280
    [Abstract] [Full Text] [Related]

  • 20. Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial.
    Rimassa L, Santoro A.
    Expert Rev Anticancer Ther; 2009 Jun 10; 9(6):739-45. PubMed ID: 19496710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.